Perbandingan EVA, MVA dan FVA Perusahaan Sub Sektor Farmasi yang Terdaftar di BEI Pada Saat dan Sesudah Pandemi Covid 19
DOI:
https://doi.org/10.35870/emt.v8i4.2216Keywords:
Financial Performance, COVID-19 Pandemic, Economic Value Added (EVA), Market Value Added (MVA), Financial Value Added (FVA)Abstract
This research investigates the financial performance of pharmaceutical sub-sector companies listed on the Indonesia Stock Exchange (IDX) during and after the COVID-19 pandemic by analyzing Economic Value Added (EVA), Market Value Added (MVA), and Financial Value Added (FVA). The study aims to determine the impact of the pandemic on these companies' ability to create value for their shareholders and improve financial performance. A sample of 11 pharmaceutical companies was selected using purposive sampling, focusing on firms that have consistently reported financial data before, during, and after the pandemic. The Wilcoxon Signed Ranks Test was employed to assess the significance of differences in performance metrics over the two periods. Results show that there is no significant difference in the financial performance during and after the pandemic when measured using the EVA and FVA methods, indicating resilience in the intrinsic value creation capabilities of these companies. However, a notable difference was found in the MVA, reflecting changes in market perceptions and investor confidence. These findings suggest that while intrinsic financial metrics remained stable, external market factors significantly influenced company valuations.
Downloads
References
Amelia, F. (2021). Analisis kinerja keuangan menggunakan metode Economic Value Added (EVA) dan Financial Value Added (FVA) pada LKM Maju Bersama program PNPM Mandiri Kelurahan Limbungan Baru Kecamatan Rumbai Pesisir Kota Pekanbaru (Skripsi, Universitas Islam Riau).
Hidayat, W. W. (2017). Dasar-dasar analisa laporan keuangan. Ponorogo: Uwais Inspirasi Indonesia.
Irfani, A. S. (2020). Manajemen keuangan dan bisnis teori dan aplikasi. Jakarta: Gramedia Pustaka Utama.
Kariyoto. (2017). Analisa laporan keuangan (Cetakan pertama). Malang: UB Press.
Kartini, & Hermawan, G. (2018). Economic Value Added dan Market Value Added terhadap return saham. Jurnal Keuangan dan Perbankan, 3(3), 355–368.
Mulyanti, D. (2017). Manajemen keuangan perusahaan. Jurnal Ilmiah Akutansi (AKURAT), 8(2), 62–71.
Prasetya, V. (2021). Analisis kinerja keuangan perusahaan sebelum dan saat pandemi Covid-19 pada perusahaan farmasi yang tercatat di Bursa Efek Indonesia. Cerdika: Jurnal Ilmiah Indonesia, 1(5), 579–587.
Pudjiprokoso, Z. (2018). Analysis of financial performance using Economic Value Added (EVA) and Financial Value Added (FVA) methods at PT Astra Agro Lestari Tbk period 2013–2017 (Skripsi, Samarinda State Polytechnic Indonesia).
Putra, S., et al. (2021). Pengukuran kinerja keuangan menggunakan analisis rasio keuangan sebagai dasar penilaian kinerja keuangan (Studi kasus: CV Sumber Makmur Abadi Lampung Tengah). Jurnal Ilmiah Sistem Informasi Akuntansi, 1(1), 48–59.
Putri, K. A., & Tumewu, J. (2019). Analisis pengaruh Economic Value Added (EVA) dan Return On Asset (ROA) terhadap Market Value Added (MVA) pada perusahaan manufaktur yang terdaftar pada Bursa Efek Indonesia. Liability, 1(1), 25–42.
Putri, Y. H. (2021). Market Value Added sebagai alat pengukur kinerja perusahaan dan harga saham. Juripol, 4(1), 320–332.
Renaldi, A. D., & Utiyati, S. (2016). Analisis rasio keuangan dan metode Economic Value Added untuk menilai kinerja keuangan. Jurnal Ilmu dan Riset Manajemen (JIRM), 5(4), 1–21.
Rusmana, R. R. (2018). Analisis perbandingan kinerja keuangan sebelum dan sesudah merger dengan menggunakan metode Economic Value Added (EVA), Market Value Added (MVA), dan Financial Value Added (FVA) (Studi kasus pada PT. XL Axiata Tbk.) (Skripsi, Universitas Telkom).
Sa’diyah, H., Hidayat, R. R., & Husaini, A. (2015). Analisis dampak merger terhadap Economic Value Added (EVA) dan Market Value Added (MVA) (Studi pada perusahaan di Bursa Efek Indonesia yang melakukan merger tahun 2011). Jurnal Administrasi Bisnis (JAB), 24(1), 1–9.
Safira, N., & Usman, S. (2021). Analisis kinerja keuangan dengan menggunakan metode EVA, MVA, FVA, REVA pada perusahaan sub sektor semen yang terdaftar di Bursa Efek Indonesia periode 2016–2020. Open Jurnal Sistem, 16(2), 6377–6390.
Setkab.go.id. (2021, December 15). Menperin: Industri pengolahan kontributor terbesar pertumbuhan ekonomi triwulan II-2021. https://setkab.go.id/menperin-industri-pengolahan-kontributor-terbesar-pertumbuhan-ekonomi-triwulan-ii-2021/
Sunardi, N. (2018). Analisis Economic Value Added (EVA), Financial Value Added (FVA), dan Market Value Added (MVA) dengan time series approach sebagai alat penilaian kinerja keuangan (Studi pada industri konstruksi (BUMN) di Indonesia yang listing di BEI tahun 2013–2017). JURNAL SEKURITAS (Saham, Ekonomi, Keuangan dan Investasi), 2(1), 62–76.
Ulya, N. F., & Jatmiko, B. P. (2020, August 5). Pertumbuhan ekonomi RI minus 5,32 persen pada kuartal II-2020. Kompas. https://money.kompas.com/read/2020/08/05/120854826/pertumbuhan-ekonomi-ri-minus-532-persen-pada-kuartal-ii-2020
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Tutut Handayani, Iis Anisa Yulia, Dewi Fitrianti
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
1. Copyright Retention and Open Access License
Authors retain copyright of their work and grant the journal non-exclusive right of first publication under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
This license allows unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
2. Rights Granted Under CC BY 4.0
Under this license, readers are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, including commercial use
- No additional restrictions — the licensor cannot revoke these freedoms as long as license terms are followed
3. Attribution Requirements
All uses must include:
- Proper citation of the original work
- Link to the Creative Commons license
- Indication if changes were made to the original work
- No suggestion that the licensor endorses the user or their use
4. Additional Distribution Rights
Authors may:
- Deposit the published version in institutional repositories
- Share through academic social networks
- Include in books, monographs, or other publications
- Post on personal or institutional websites
Requirement: All additional distributions must maintain the CC BY 4.0 license and proper attribution.
5. Self-Archiving and Pre-Print Sharing
Authors are encouraged to:
- Share pre-prints and post-prints online
- Deposit in subject-specific repositories (e.g., arXiv, bioRxiv)
- Engage in scholarly communication throughout the publication process
6. Open Access Commitment
This journal provides immediate open access to all content, supporting the global exchange of knowledge without financial, legal, or technical barriers.
